New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|October 1, 1995
The American Journal of Managed Care
- October 1995
- Volume 1
- Issue 2
Prevention and Treatment of Osteoporosis
Author(s)Gloria A. Bachmann, MD
Advertisement
Articles in this issue
almost 31 years ago
The Safety and Efficacy of Continuous Heparin Infusion Therapy in the Homealmost 31 years ago
Partial Medication Compliance: The Enigma in Poor Medical Outcomesalmost 31 years ago
The Integration of Case Management and Pharmacy in Managed Care Environmentsalmost 31 years ago
Comparing Quality in Managed Care and Fee-for-Service Delivery Systemsalmost 31 years ago
Concentration of Healthcare Costs in AsthmaAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement